Armonk, N.Y.-based IBM and Woonsocket, R.I.-based CVS Health announced today that they have partnered to pair predictive analytics with IBM Watson's cognitive computing platform with an aim to transform care management services for chronic disease patients.
Watson's cognitive computing capabilities will enable clinicians, including CVS Health practitioners, to tap into large amounts of data, advancing care management programs and services.
"The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health's insights into medication utilization and patient behavior, could prove transformative for the industry," Mike Rhodin, senior vice president for IBM Watson said in a statement. "Improving care for people with chronic conditions supports IBM's commitment to make big plays that advance the health and well-being of the global community. Through the recent acquisitions of Phytel, Explorys and Curam we also bring extraordinary capabilities in patient engagement and population health, enabling us to deliver a powerful solution that supports individuals wherever they are, whenever they need it."
The joint CVS Health/IBM Watson Health solution will help to predict when individuals are at risk for declining health and encourage them to adopt safe and healthy behaviors. This includes patients with chronic diseases such as hypertension, heart disease, diabetes and obesity. The technology will be capable of encouraging adherence to prescribed medicines and healthy lifestyle regimens, creating customized engagement programs and suggesting appropriate use of primary care and outpatient providers.